1 |
Raphael BJ, Hruban RH, Aguirre AJ, et al. Integrated genomic characterization of pancreatic ductal adenocarcinoma[J]. Cancer Cell, 2017,32(2):185-213.
|
2 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin Wiley, 2019,69:7-34.
|
3 |
Freddie, Bray, Jacques, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: a cancer journal for clinicians, 2018,394-424.
|
4 |
Kaur S, Baine MJ, Jain M, et al. Early diagnosis of pancreatic cancer: challenges and new developments[J]. Biomarkers in Medicine, 2012,6(5):597-612.
|
5 |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J ClinAmerican Cancer Society, 2013,63:11-30.
|
6 |
杨春明.实用普通外科手术学[M].北京:人民卫生出版社,2014,842-889.
|
7 |
Cooperman AM, Hoerr SO. Surgery of the pancreas: a textand atlas[M]. CV Mosby: St Louis, 1978.
|
8 |
Warshaw AL. Conservation of the spleen with distal pancreatectomy[J]. Arch Surg, 1988,123(5):550-553.
|
9 |
Gagner M, Pomp A, Herrera MF. Early experience with laparoscopic resections of islet cell tumors[J]. Surgery, 1996,120:1051-1054.
|
10 |
Kimura W, Inoue T, Futakawa N, et al. Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein[J]. Surgery, 1996,120:885-890.
|
11 |
Benoist S, Dugué L, Sauvanet A, et al. Is there a role of preservation of the spleen in distal pancreatectomy[J]. J Am Coll Surg, 1999,188:255-260.
|
12 |
Shoup M, Brennan MF, McWhite K, et al. The value of splenic preservation with distal pancreatectomy[J]. Arch Surg, 2002,137:164-168.
|
13 |
Antoniou GA, Riga CV, Mayer EK, et al. Clinical applications of robotic technology in vascular and endovascular surgery[J]. J Vasc Surg, 2011,53(2):493-499.
|
14 |
Rubin LG, Schaffner W. Clinical practice. care of theasplenic patient[J]. New England Journal of Medicine, 2014,371(4):349-356.
|
15 |
Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminaryresults of the MRC randomised controlled surgical trial[J]. The surgical cooperative group. Lancet, 1996,347:995-999.
|
16 |
Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resectionsfor gastric cancer: long-term results of the MRC randomized surgical trial[J]. Surgical Co-operative Group. BrJ Cancer, 1999,79:1522-1530.
|
17 |
Griffith JP, Sue-Ling HM, Martin I, et al. Preservation of the spleen improvessurvival after radical surgery for gastric cancer[J]. Gut, 1995,36:684-690.
|
18 |
McGory ML, Zingmond DS, Sekeris E, et al. Thesignificance of inadvertent splenectomy during colorectalcancer resection[J]. Arch Surg, 2007,142:668-674.
|
19 |
Jung M, Morel P, Buehler L, et al. Robotic general surgery: current practice,evidence, and perspective[J]. Langenbecks Arch Surg, 2015,400(3):283-292.
|